-
Saving Eyes While Saving Lives
A chemo combo pioneered at St. Jude retains a high cure rate for retinoblastoma while preserving usable vision and lowering future cancer risk.
-
Patients Pay it Forward
St. Jude Child Life unites five patients and inspires them to help one another persevere.
-
Melanoma: Signs and Subtypes
For decades, the genetic basis of pediatric melanoma was a mystery. But St. Jude scientists recently discovered the molecular signatures of three pediatric melanoma subtypes.
-
Ewing Sarcoma: Changing Hues
A spectrum of discoveries in St. Jude labs and clinics offer promise for patients with Ewing sarcoma.
-
St. Jude Proton Therapy: Think Positive
St. Jude opens the first proton therapy center designed just for children.
-
The St. Jude Melanoma Clinic
A new clinic brings families from across the nation to St. Jude to increase our knowledge about this aggressive type of skin cancer.
-
Spurred into Action: Discovering the Origins of Rhabdomyosarcoma
In the race to increase survival rates for the soft-tissue cancer, one researcher proved rhabdomyosarcoma can originate in the inner surface of blood vessels.
-
Survivor Heeds a Calling to Care
For childhood cancer survivor Ashley McTyre, RN, nursing is not a career, but a calling.
-
Saving Eyes and Lives Worldwide
St. Jude harnesses technology to aid in the early detection and diagnosis of the eye cancer retinoblastoma.
-
Immunotherapy: Power from Within
A promising new therapy mobilizes a child’s immune system to help kill cancer cells.
